Clinical Trials Directory

Trials / Completed

CompletedNCT00612625

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Near Normalisation of Blood Glucose Improves the Potentiating Effect of GLP-1 on Glucose Induced Insulin Secretion in Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The ability of glucagon-like peptide 1 to enhance beta-cell responsiveness to I.v. glucose is impaired in patients with type 2 diabetes mellitus compared with healthy individuals. We investigated whether 4 weeks of near-normalisation og blood glucose improves the potentiation of glucose-stimulated insulin secretion by GLP-1

Conditions

Interventions

TypeNameDescription
DRUGglucagon-like peptide-1continuous infusion of GLP-1 (1½ pmol/kg/min)
DRUGSalinecontinuous infusion of saline

Timeline

Start date
2004-02-01
Primary completion
2004-07-01
Completion
2004-12-01
First posted
2008-02-12
Last updated
2008-02-12

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00612625. Inclusion in this directory is not an endorsement.